Related Experiment Video
Updated: Jul 3, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Severe amlodipine intoxication treated by hyperinsulinemia euglycemia therapy
Hicham Azendour1, L Belyamani, M Atmani
1Medical Critical Care Unit, Military Hospital of Mohamed V, Rabat, Morocco.
The Journal of Emergency Medicine
|July 29, 2008
Summary
Hyperinsulinemia euglycemia therapy effectively treated severe amlodipine intoxication, reversing dangerous hypotension. This insulin therapy shows promise as a first-line treatment for calcium channel blocker overdose.
Area of Science:
- Toxicology
- Cardiology
- Endocrinology
Background:
- Severe amlodipine intoxication can lead to life-threatening hypotension.
- Standard treatments like fluids and vasopressors may be insufficient in critical cases.
Observation:
- A patient with severe amlodipine overdose experienced refractory hypotension despite conventional therapy.
- Hyperinsulinemia euglycemia therapy was administered as a last resort.
Findings:
- Following insulin administration, a significant rise in blood pressure was observed within 30 minutes.
- The patient's blood pressure became responsive to epinephrine after insulin therapy.
- Mechanical ventilation was discontinued within 24 hours, and the patient stabilized.
Implications:
- Hyperinsulinemia euglycemia therapy demonstrates a potential positive inotropic effect in calcium channel blocker intoxication.
- This therapy should be considered a potential first-line treatment for severe amlodipine overdose.
- Further research is warranted to confirm the efficacy and safety of this therapeutic approach.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...